Genmab Q4 EPS $0.05 Misses $0.44 Estimate, Sales $1.058B Miss $4.401B Estimate
Genmab A/S -3.31%
Genmab A/S GMAB | 28.33 | -3.31% |
Genmab (NASDAQ:
GMAB) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.44 by 88.64 percent. This is a 94.12 percent decrease over earnings of $0.85 per share from the same period last year. The company reported quarterly sales of $1.058 billion which missed the analyst consensus estimate of $4.401 billion by 75.96 percent. This is a 14.81 percent increase over sales of $921.559 million the same period last year.